Sarepta grants new CEO Severino options for 2,224,342 shares at $17.74, plus 756,104 RSUs
SRPT•New CEO equity grant
Sarepta Therapeutics granted new CEO Michael Severino stock options for 2,224,342 shares and 756,104 restricted stock units on July 28, 2026.
- Options carry a $17.74 exercise price, set at a 15% premium to the stock’s July 28 closing price.
- Options vest 25% after one year, then monthly, reaching full vesting after four years.
- RSUs vest in four equal annual installments, reaching full vesting after four years.
